Mycronic Raises Guidance: Why We're Still on the Sidelines

Mycronic just raised full-year guidance after a surprise rebound in equipment orders, and the stock already popped on the news. Here's what's actually driving the turnaround, and why we're still on the sidelines.

Mycronic is a Swedish semiconductor equipment company that plays on the edges of the core wafer fab process, supplying pattern generators for photomask production, along with test, chip packaging, and PCB assembly equipment. In this episode, we break down Mycronic's Q2 2026 earnings, including a 7% year-over-year decline in its largest segment, Pattern Generators, offset by a 118% surge in Global Technologies, its fastest-growing test and packaging business. We also cover the smaller High Volume and PCB Assembly Solutions segments, one of which is undergoing restructuring after a recent acquisition underperformed.

Combined net sales grew 17% year over year, and management raised full-year 2026 guidance by roughly 500 million SEK. We dig into Mycronic's tuck-in acquisition strategy, balance sheet strength (net cash, minimal debt), and run a reverse discounted cash flow model to estimate fair value.

If you're looking for semiconductor equipment exposure beyond the "Fab Five" — ASML, Applied Materials, Lam Research, Tokyo Electron, and KLA — Mycronic is worth understanding, even if it's not a stock we're buying right now.

Semi Insider members get access to CSI's research platform and tools plus deeper research as it happens. Join at chipstockinvestor.com.

Full research and stock tools: https://chipstockinvestor.com
Get 15% off your fiscal.ai membership with our link: https://fiscal.ai/csi

Content in this podcast is for general information or entertainment only and is not specific or individual investment advice. Forecasts and information presented may not develop as predicted, and there is no guarantee any strategies presented will be successful. All investing involves risk, and you could lose some or all of your principal.